NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today reported another period of strong results for the first fiscal quarter ended October 31, 2015.
First Quarter Highlights
• Strong financial performance at Enzo Clinical Labs and new legal settlements contributes to year-over year revenues and net income gains.
First Quarter Highlights
• Strong financial performance at Enzo Clinical Labs and new legal settlements contributes to year-over year revenues and net income gains.
